Share:

Research & Education: Overactive-bladder Treatment

Reprinted from PN September 2001
View Forum | Print Article | Font Size + / - | Back
The University of Pittsburgh Medical Center Health System has issued a press release regarding safe and effective treatment for overactive bladder in people with spinal-cord injury (SCI) or multiple sclerosis (MS).

According to the information, extended-release oxybutynin (Ditropan XL) is a safe and effective treatment.

For people with SCI and MS, damage to the nervous system can cause a condition referred to as "neurogenic bladder." These patients experience a malfunction of the autonomic nerves that control bladder function, resulting in overactive bladder.

Extended-release oxybutynin is one of the leading treatments for this condition, decreasing the frequency of urination with minimal side effects.

Overactive bladder affects approximately 17 million Americans, making it more prevalent than many commonly discussed conditions. It is one of the most under-diagnosed and under-treated conditions in the United States.

Contact: Jocelyn Uhl, UPMC Health System News Bureau, (412) 647-3555 / 624-3184 (fax) / UhlJH@msx.upmc.edu.

 

To read more about this, order the September 2001 PN, Click Here.
To Subscribe, Click Here.

Article Forum

PN Forum discussions are intended to provide a place for free-flowing exchange of information, opinions, and comments and are designed to provide an enjoyable and informative expression for all participants.
Please review our Forum Rules for complete details.

Login with username and password (Forgot Password?)
New Post

Research & Education: Overactive-bladder Treatment

0 Comments


Be the first to comment on this article.
(Register or login to add comments.)